Portal Veterinary medicinal products

Menu Medicaments Vétérinaires

Rubrics

Menu Medicaments Vétérinaires

Meeting of Heads of Agency (HMA) from 4 to 6 May 2022
12/05/2022
News

Meeting of Heads of Agency (HMA) from 4 to 6 May 2022

The French agency for veterinary medicinal products (Anses-ANMV) organised with Ansm (French agency for human medicines) the second meeting of Heads of Agency (HMA) from 4 to 6 May. The meeting was held at the Palais du Grand Large in Saint Malo with 90 participants from the competent European authorities, the European Commission and the European Medicines Agency (EMA). On the first day, a meeting was organised with stakeholders: representatives of the veterinary medicine industry, veterinarians, farmers and the veterinary diagnosis industry. Among other things, the meeting provided an opportunity to discuss the implementation of the Veterinary Regulations. On May 5th and 6th, the heads of medicines agencies met for a day and a half. At the veterinary session, the European strategy HMA-EMA 2021-2025 on “Big Data” was adopted as well as the Action Plan of the Network of Agencies’ 2025 Strategy. Part of this event was dedicated to medical devices for human use.
A new process for monitoring adverse reactions to veterinary medicines
04/05/2022
News

A new process for monitoring adverse reactions to veterinary medicines

A new EU-wide pharmacovigilance scheme has been launched with the new EU Regulation on veterinary medicinal products. It aims to manage the adverse effects of veterinary medicines and applies to all medicines authorised in at least one European Union country. We put three questions on this new process to Sylviane Laurentie, deputy director of the French Agency for Veterinary Medicinal Products, responsible for inspection, surveillance and pharmacovigilance.
PFUE — European Conference on the Use of Plants in Veterinary Medicine
08/04/2022
News

PFUE — European Conference on the Use of Plants in Veterinary Medicine

As part of the French Presidency of the Council of the European Union (PFUE), the French agency for veterinary medicinal products (Anses-ANMV) organised a European conference on the use of plants in veterinary medicine on 29 March. The conference, intended for the competent European authorities, was held remotely and attended 54 participants from outside the Anses.
Three new databases for greater transparency on veterinary medicinal products in Europe
07/03/2022
News

Three new databases for greater transparency on veterinary medicinal products in Europe

The new Regulation (EU) No 2019/6 on veterinary medicinal products provides for the creation of three databases, designed to improve access to and sharing of information on these products. Here is an overview of their objectives.
Human hormonal treatments: be careful not to expose your pets
21/01/2022

Human hormonal treatments: be careful not to expose your pets

In dogs and cats, repeated contact with their owner’s topical hormone replacement therapy can cause hormonal problems. Following reports of adverse effects in several European countries, ANSES-ANMV (French Agency for Veterinary Medicinal Products) is inviting owners to apply these medications with the necessary precautions to avoid exposing their pets.
What does the new European regulation on veterinary medicinal products change?
28/01/2022
News

What does the new European regulation on veterinary medicinal products change?

The new European regulation on veterinary pharmaceuticals came into force on 28 January 2022. The Director of the French Agency for Veterinary Medicinal Products (ANMV), Jean-Pierre Orand, assesses what will change.
Phytotherapy and aromatherapy: adapting risk assessment in veterinary medicine
24/01/2022

Phytotherapy and aromatherapy: adapting risk assessment in veterinary medicine

Herbal preparations (phytotherapy) and essential oils (aromatherapy) are increasingly being used as alternatives to other “allopathic” medicinal products for the treatment of animals. This is true even for food-producing animals. If the products used have a therapeutic purpose, they are considered veterinary medicinal products.This means it should be possible to guarantee there is no risk to consumers of foods derived from treated animals. However, it is complicated to implement the current regulations to assess this risk for herbal medicinal products. ANSES therefore issued an internal request to propose a specific assessment methodology for herbal veterinary medicinal products.
Informal meeting of the Committee for Veterinary Medicinal Products (CVMP — CMDv)
30/05/2022

Informal meeting of the Committee for Veterinary Medicinal Products (CVMP — CMDv)

Public : non
As part of the French Presidency of the Council of the European Union (PFUE), the ANMV organises the biannual meeting of the two main bodies involved in the authorisation process for veterinary medicinal products in Europe from 30 May to 2 June 2022: the Coordinating Group on Mutual and Decentralised Recognition Procedures — Veterinary (CMDv) and the Committee for Medicinal Products for Veterinary Use (CVMP), Expert Group at the European Medicines Agency (EMA).

Ça peut aussi vous intéresser

Three questions for Philippe Reignault, Director of Plant Health and Director of the Plant Health Laboratory at ANSES
22/02/2020
News

Three questions for Philippe Reignault, Director of Plant Health and Director of the Plant Health Laboratory at ANSES

The health of plants is increasingly threatened. What issues need to be addressed to better protect them? "Pests, especially plant pests, are one of the major contributors to the loss of production and biodiversity worldwide. Diseases and pests are emerging or re-emerging with greater frequency, affecting plant health and by extension the environment, our food and our health. Tackling these threats is costly, and if we add this to the resulting production losses, it translates into several billion euros invested or lost each year worldwide. To preserve crops and the diversity of species unique to each ecosystem, it is vital to avoid the introduction or establishment of these organisms in new areas, especially since it is often very difficult to eradicate them once they have become established. Anticipating and reducing these risks also means we can avoid or limit the use of plant protection products. It is therefore essential to take effective precautions to avoid major consequences, and even health emergencies." What action is ANSES – in particular its Plant Health Laboratory – taking to address these issues? "At ANSES, plant health mobilises highly specialised scientific expertise to support the public authorities in their prevention and control measures, both nationally and internationally. With more than 40 years of experience in the field, the ANSES Plant Health Laboratory brings together 90 employees, in particular scientists with sought-after skills in mycology, entomology, virology, etc. The Laboratory has six sites in metropolitan France and the overseas territories. It has cutting-edge technologies and unique systems, such as the quarantine system, which means it can confine and study plants brought into the country for research or varietal selection purposes. It is the National Reference Laboratory for all plant pests (bacteria, viruses, fungi and oomycetes, nematodes, invasive plants and insects) and for many of them is also the European Union Reference Laboratory. As such, it plays a major role in hazard detection and risk assessment in plant health. The ANSES Lyon Laboratory also studies phenomena of resistance to plant protection products and is involved in outbreak surveillance." What are the challenges to be met in order to continue to support control measures? "Faced with increasingly diverse and globalised threats and emerging phenomena, we need to be particularly vigilant and responsive to ensure that advances in science keep pace with these changes. This means generating ever more comprehensive scientific knowledge and developing more powerful analytical methods to rapidly detect and identify pathogens and pests. The aim is to strengthen surveillance and response capabilities when alerts occur. A new European regulatory framework on plant health has recently been adopted, which involves proposing appropriate measures in terms of plant imports, for example. The challenge is to go ever further and faster in our work thanks to technological progress, such as in genome sequencing, for example. We must also give ourselves the means – and we are working to do so – to act with greater synergy at European and international level by mobilising the entire scientific community and pooling our efforts."
Recognising the carcinogenic nature of work involving exposure to welding fumes
14/04/2022
News

Recognising the carcinogenic nature of work involving exposure to welding fumes

In France, more than 528,000 employees are potentially exposed to welding fumes. According to the latest available data, inhaling these fumes containing metal particles can cause lung and throat cancer. Following its expert appraisal, ANSES thus recommends including work involving exposure to welding fumes and metal fumes from related processes in the Order listing carcinogenic substances, mixtures and processes as defined in the French Labour Code.
Beware of ticks in forests or gardens
03/05/2022
News

Beware of ticks in forests or gardens

Especially active in the spring and autumn, ticks are the main vectors of pathogens responsible for infectious diseases in Europe. In particular, they transmit the bacterium that causes Lyme disease in humans. Bites can occur in woods and forests, but also in gardens.